Currently, there are no drugs specifically approved to treat sepsis, although some drugs were (unsuccessfully) trialled that target particular inflammatory pathways, for example, Cytofab, a drug made by AstraZeneca, targeting TNF-α [116]. Here, TNF is linked to Sepsis.